Part 5/11:
Central to the arguments against the presence of nanotechnology in vaccines is the ongoing critique that regulatory bodies have failed to conduct adequate studies on their safety or compositional integrity. This raises pertinent questions: why are the exact ingredients of the vaccine vials still unknown? And why have certain lots been implicated in higher incidences of adverse reactions?